Project Description
Origo Biopharma
Origo Biopharma, S.L.
Innovative small molecules to treat the immune system
Origo is a biotech company developing a new generation of therapeutic products for the treatment of several diseases linked to TGF-β in gastrointestinal and lung indications. Founded by biotech/pharma executives from Palobiopharma and Galchimia.